biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Why do we still get buying of shares from tine ti time?

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Mar 08, 2024 10:09am

144 Views

Post# 35922540

RE:RE:RE:RE:RE:RE:RE:Why do we still get buying of shares from tine ti time?

beenthere wrote: Would this not be a good case implying xB3 did not do what it should at least for Chiesi?

Doesn't look good when Chiesi spent millions of dollars and years on xB3 and they drop it and move onto someone else in a quest for the answer to the same problem.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024